baber/WOPTO huggingface dataset:
Patent NZ-580030-A (NZ)
Title: Methods of treatment using glycopegylated g-csf
Inventor: ZOPF DAVID A
IPC: C07K1/00
Filed: 2008-04-01
Abstract: Disclosed is the use of an amount of a peptide which is a covalent conjugate between a granulocyte colony stimulating factor ( G-CSF ) peptide and a polymeric modifying group, wherein said polymeric modifying group is covalently attached to said peptide at a glycosyl or amino acid residue of said peptide via a glycosyl linking group, wherein said amino acid residue is asparagine, threonine or serine, and wherein said polymeric modifying group is a water-soluble polymer ( poly(ethylene glycol )), in the manufacture of a medicament for preventing infection, for treating severe chronic or relative leukopenia, acute myeloid leukemia, AIDS or other immunodeficiency diseases, bacterial infections, heart diseases, angina, Hepatitis A, B and C, compromised immunity and compromised white blood cell production, idiopathic thrombocytopenia purpura, neutropenia, febrile neutropenia, thrombocytopenia, for preventing or reducing the occurrence of acute rejection of organ transplants in a patient, for improving heart function, for treating neurological diseases, Alzheimer's disease and other degenerative disorders.
Patent NZ-583473-A (NZ)
Title: System and method for pulverizing and extracting moisture
Inventor: GRAHAM WILLIAM
IPC: G01N29/46
Filed: 2005-01-20
Abstract: A venturi (18) receives incoming material through an inlet tube (12) and subjects the material to pulverization. The material, as it undergoes pulverization, is further subject to moisture extraction and drying. An airflow generator (32), coupled to the venturi (18), generates a high speed airflow to pull the material through the venturi and into an inlet aperture in the airflow generator. The airflow generator directs the received pulverized material to an outlet where the material may be subsequently separated from the air. An automatic balancer system (1008) couples to an axle rotating the airflow generator to provide balance, improve efficiency, and eliminate cavitation. (62) Divided Out of 550689
Patent NZ-589599-A (NZ)
Title: A fastening tool with an internal combustion engine with opening and closing chamber abutment
Inventor: ROUSSON LUDOVIC
IPC: F16F7/00
Filed: 2010-11-29
Abstract: Disclosed is a pressure regulating breathing assistance apparatus (100) which can produce pressure oscillations having high amplitudes, a low broad-band frequency spectrum and long time duration for use in CPAP for infants. The apparatus includes a pressurized gas source (110); a container of fluid (160) and a conduit (140). The conduit has proximal (141) and distal ends (145). The proximal end is adapted for connection to the pressurized gas source. The distal end has at least one peak inspiratory pressure control conduit configured to be submerged in the body of fluid at varying depths and at least one positive end-expiratory pressure control conduit configured to be submerged in the body of fluid at varying depths and a valve (125) intermediate the at least one peak inspiratory pressure control conduit and the at least one positive end-expiratory pressure control conduit. The conduit is also adapted for connection to a patient interface (130) intermediate the proximal and distal ends. The device can control the oscillatory amplitude, frequency range and composition, time duration, and mean airway pressure levels by adjusting certain device parameters, such as the angle and depth of the device in the fluid. A device and mechanical system for remotely adjusting and measuring the angle of the device in a fluid are also disclosed. Furthermore, a device and system are disclosed that can deliver pressure oscillations having high amplitudes, a low broad-band frequency spectrum, long time duration, and multiple mean airway inspiratory and expiratory pressure levels. The device and system also provide means for controlling respiration timing in a patient, including: breaths per minute, inspiratory time, and the ratio of inspiratory to expiratory time.
Patent NZ-593647-A (NZ)
Title: Synthesis of purine nucleosides
Inventor: SOFIA MICHAEL JOSEPH
IPC: A61K31/7076
Filed: 2009-12-23
Abstract: ABSTRACT - 593647 The disclosure relates to process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound represented by formula (II), its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof, wherein R7 is C1-6 alkyl or C3-6 cycloalkyl and R8 is -O(C1-6 alkyl) or -O(C3-6 cycloalkyl). These compounds are suitable for the treatment of a hepatitis C virus infection.
Patent NZ-594694-A (NZ)
Title: Process for the production of biofuel from plant materials
Inventor: BELANGER HELENE
IPC: C13K1/02
Filed: 2007-05-08
Abstract: Disclosed is a method for extracting hemicellulose sugars from lignocellulsic plant material, comprising: contacting lignin-depleted lignocellulosic plant material solids with water at an elevated temperature and at an elevated pressure, substantially in the absence of an introduced acid catalyst, under conditions that promote extraction of hemicellulose sugars, from the lignin-depleted lignocellulosic plant material solids to produce: i) an aqueous mixture comprising water-soluble hemicellulose sugars and ii) treated plant material solids comprising cellulose in a hydrolysable pulp; separating the aqueous mixture from the treated plant material solids; and recovering hemicellulose sugars from the aqueous mixture.
Patent NZ-595436-A (NZ)
Title: A batch loader with a drop conveyor having a guide able to adjust the lateral position of the items being conveyed
Inventor: VIGLUNDSSON ADALSTEINN
IPC: B65B25/06
Filed: 2010-04-28
Abstract: The present invention relates to an apparatus for delivering one or more items (2) to a desired position on an item carrier (8), the apparatus comprising a drop conveyor comprising two conveyor sections (3, 4) that are laterally displaceable and controllable in order to enable dropping the one or more items (2) at a desired position along the length of the drop conveyor. The drop conveyor comprises guide means (5, 6) placed above the two conveyor sections (3, 4), the guide means (5, 6) being laterally displaceable and controllable. The present invention further relates to a method of delivering one or more items (2) to a desired position on an item carrier (8), the method comprising the steps of positioning the item carrier (8) beneath a drop conveyor, transferring one or more items to the drop conveyor, positioning the items on the drop conveyor, adjusting side guides (5, 6) into contact with the items, and opening the drop conveyor so that the items are dropped.
Patent NZ-597808-A (NZ)
Title: Ultra high barrier aseptic film and package
Inventor: BEKELE SOLOMON
IPC: B32B27/28
Filed: 2010-06-29
Abstract: A coextruded multilayer film includes a core layer including a polyamide; two intermediate layers each including an ethylene vinyl alcohol copolymer; a first and second outer layer each including an olefinic copolymer or an amorphous cyclic olefin copolymer; and two tie layers each adhering an intermediate layer to a respective outer layer; the ethylene vinyl alcohol copolymer of the first intermediate layer having a mole % ethylene at least 5 greater than the mole % ethylene of the ethylene vinyl alcohol copolymer of the second intermediate layer An aseptic package includes a sterilized food product, and a sterilized pouch in which the sterilized food product is disposed, the sterilized pouch including the film of the invention. A method of making an aseptic package is also disclosed.
Patent NZ-598040-A (NZ)
Title: Use of cajeput and pimenta racemosa extract for treating parasitic infestation of fish
Inventor: SCHELKLE BETTINA
IPC: A23K1/00
Filed: 2010-08-09
Abstract: Patent No. 598040 Disclosed is a use of a combination of cajeput and Pimenta racemosa extract for preventing ornamental fish parasite infestation or removing ornamental fish parasites.
Patent NZ-598247-A (NZ)
Title: Compositions and methods for treating parkinson’s disease
Inventor: SEEMAN PHILIP
IPC: A61P25/28
Filed: 2010-07-30
Abstract: 598247 Disclosed herein are compositions of receptor inhibitors, including typical antipsychotic agents, for example haloperidol, and methods of use for treating clinical signs or symptoms of Parkinson’s disease. Furthermore, this application describes compositions and methods to induce supersensitivity in dopamine D2 and other receptors involved in Parkinson’s disease as a means of alleviating the clinical signs or symptoms of Parkinson’s disease.
Patent NZ-600019-A (NZ)
Title: Electromagnetic valve device
Inventor: RENDESI MAURIZIO
IPC: F16K31/00
Filed: 2010-11-22
Abstract: 600019 Disclosed is a solenoid valve device (1). The device includes a body (2, 7) with an inlet (3) and an outlet (4) for a fluid, and a main valve seat (6) through which the fluid can flow from the inlet (3) to the outlet (4). A main plug (8, 9) is movable with respect to the valve seat (6) between a closed position and an open position of the valve seat (6). A control chamber (11) formed in the body (2, 7) and is partially delimited by the main plug (8). For communication between the inlet (3) and the control chamber (11) there is at least a first passage (8d, 9b, 9c) and at least a second passage (12, 13) for putting the control chamber (11) into communication with the outlet (4). A control solenoid valve (14) with a control solenoid (15) controls a unit (17). The unit (17) is movable in the solenoid (15) and has a first ferromagnetic core (18) which can interact as a movable plug with the second passage (12, 13). The movable unit (17) has an additional or second movable ferromagnetic core (21) positioned in the solenoid (15) adjacent to one end of the first core (18), and positioning means (19, 20, 22) are provided for keeping the second movable core (21) permanently connected to the main plug (8, 9). When the solenoid (15) is inactive, the positioning means keeps the first core (18) in the closed position of the second passage (12, 13) and the second core (21) in a predetermined position with respect to the first core (18) and to the solenoid (15) such that the cores (18, 21) are separated by a gap (24). The positioning means has a substantially non-magnetic spacer element (19) which extends between the main plug (8, 9) and the second movable core (21). The arrangement is such that the energizing of the solenoid (15) causes the first core (18) to be attracted towards the second core (21) and causes the second passage (12, 13) to be opened, and a flow of fluid from the inlet (3) passes through the first passage (8d, 9b, 9c) to the control chamber (11). The solenoid valve device is characterised in that the spacer element (19) extends with a radial clearance within the solenoid (15) and around the first core (18) and which has at least one aperture (23) in the proximity of the second core (21). The arrangement is such that, when the solenoid (15) is activated, a flow of fluid flows between the solenoid (15) and the spacer element (19) towards the second core (21), and then flows through the at least one aperture (23) of the spacer element (19) between the spacer element (19) and the first core (1S) towards the second passage (13, 12).
Patent NZ-602635-A (NZ)
Title: Methods of enhancing drug delivery and effectiveness of therapeutic agents
Inventor: DESAI NEIL P
IPC: A61K31/337
Filed: 2011-03-28
Abstract: Disclosed are methods of enhancing the uptake of a therapeutic agent in a target tissue as well as methods of treating a disease (such as cancer) or enhancing effectiveness of treatment with a therapeutic agent in an individual by co-administering a composition comprising nanoparticles comprising albumin and a poorly water soluble drug such as a taxane with the therapeutic agent. Also disclosed is a method of treatment or a method of selecting patients for treatment of a disease (such as cancer) with the combination of a therapeutic agent and a composition comprising nanoparticles comprising albumin and a poorly water soluble drug such as a taxane based on one or more characteristics of the target tissue that correlates or indicates the capability of getting enhanced therapeutic agent uptake as a result of the co-administration of the taxane nanoparticle composition in the target tissue (referred to as “the drug uptake capability”).
Patent NZ-603134-A (NZ)
Title: Method for manufacturing smoking articles and smoking articles
Inventor: KALJURA KARL
IPC: A24C5/47
Filed: 2011-03-31
Abstract: 603134 The present disclosure relates to a method for making smoking articles, smoking articles, and more particularly to a method for manufacturing smoking articles having a reduced ignition propensity. A method of manufacturing a smoking article includes the steps of providing a filter element (40) and at least one rod (30) of smokeable material surrounded by a wrapper, wrapping a section of tipping paper (12A) around the filter element and a portion of the at least one wrapped rod and applying one or more patches (12B1, 12B2) of material to the outer surface of the wrapper. The patches can be arranged to reduce the ignition propensity of the smoking article and are applied to the outside of the wrapper, such that this can occur online during manufacture of the wrapped rod.
Patent NZ-605019-A (NZ)
Title: Determining spatial orientation information of a body from multiple electromagnetic signals
Inventor: WELLINGTON ROBERT J
IPC: G01S19/53
Filed: 2011-05-18
Abstract: Disclosed is a system for determining a spatial orientation of a body frame of reference of a body with respect to a navigation frame of reference that is not dependent upon the spatial orientation of the body frame of reference. The system includes a receiver (102) adapted for co-location with the body in a fixed spatial relationship with the body which also has a directional transducer (118). The receiver (102) receives sets of electromagnetic signals from transmission sources (106) that have known locations, and detects azimuth angle information that identifies azimuth angles from which the sets of electromagnetic signals were received in relation to the body frame of reference. The detection of the azimuth angle information is based on respective measured signal amplitudes for each the sets of electromagnetic signals. The azimuth angle information partially defines directions from the body to the transmission sources (106) from which the sets of electromagnetic signals were received. A body attitude determination module receives, from the receiver (102), the azimuth angle information for at least three separate received sets of electromagnetic signals that arrive from a different one of at least three of the transmission sources (106) that have the known locations. The determination module then determines the spatial orientation, including yaw, pitch, and roll angles, of the body frame of reference with respect to the navigation frame of reference using the detected azimuth angle information for each one of the received sets of electromagnetic signals. The determination of the spatial orientation is performed without using detected elevation angle information.
Patent NZ-606220-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2007-10-26
Abstract: 606220 Disclosed is a method comprising: irradiating a lignocellulosic material in air with from about 10 Mrad to about 150 Mrad of radiation, using an electron beam, to generate carboxylic acid groups by reaction of the irradiated material with the air and thereby provide an irradiated lignocellulosic material having a larger number of carboxylic acid groups than the lignocellulosic material from which the irradiated material was obtained, and further comprising converting the irradiated lignocellulosic material to a product selected from the group consisting of alcohols, organic acids, sugars, hydrocarbons, and mixtures thereof, utilizing an enzyme and/or a microorganism.
Patent NZ-609811-A (NZ)
Title: Method and device for laying down and tensioning an impermeable cover for hydraulic works in loose material
Inventor: SCUERO ALBERTO
IPC: E02B3/16
Filed: 2012-01-12
Abstract: Disclosed are a method and system for laying down and tensioning an impermeable cover. The disclosure notes that impermeable covers are required to cover hydraulic structures consisting of loose natural material such as dams or water basins to prevent water loss or seepage and subsidence and/or erosion. The method comprises a plurality of geostrips (20) of elastically yielding synthetic material disposed on a surface of a hydraulic structure consisting of loose material. The steps for laying down and tensioning the impermeable cover comprise excavating a plurality of spaced apart trenches (14) extending in one direction. The individual trenches (14) are shaped with a regularly finished surface suitable for contacting the geostrips (20). Overlapped and unfolded edges of the plurality of geostrips (20) are laid down and sealingly connected. The surface (13) of the hydraulic structure maintains a bridging disposition of the geostrips (20) on the trenches (14). The geostrips (22) are pushed into cavities (18) of a first set of trenches (14) and a first ballasting material (23) is introduced to lock the geostrips (20). The geostrips (20) are tensioned and pushed into cavities (18) of a second set of trenches (14). A second ballasting material (22) is introduced to lock the geostrips (20) in a taut condition.
Patent NZ-617242-A (NZ)
Title: Biomarkers for predicting sensitivity to cancer treatments
Inventor: LIN KUI
IPC: G01N33/574
Filed: 2012-03-30
Abstract: Disclosed is a method of predicting the sensitivity of the growth of a tumour cell in a sample to an AKT inhibitor, comprising determining the presence of a mutation to AKT, wherein the presence of a mutation to AKT correlates with sensitivity of the cell to the AKT inhibitor, wherein the AKT inhibitor is (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5Hcyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one, or a pharmaceutically acceptable salt thereof, and wherein the mutation corresponds to, or aligns with, L52, K189 or D323. Also disclosed is the use of GDC-0068 or a salt thereof in the manufacture of a medicament for treating a cancer cell having a mutation corresponding to, or aligning with, L52, K189 or D323.
Patent NZ-619236-A (NZ)
Title: Fire retardant composition and method for treating wood
Inventor: SAARI KIMMO
IPC: B27K3/52
Filed: 2012-05-29
Abstract: Disclosed is an aqueous fire retardant composition comprising phosphoric acid, ammonium, diammonium phosphate, ammonium sulfate, urea, and a complexing agent selected from the group consisting of ethylenediamine tetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), nitrilotriacetic acid, diethylene pentaacetic acid, dodecane tetraacetic acid. The composition may optionally contain a charring agent selected from the group consisting of glycerol, zinc borate, aluminum hydrate, aluminium trihydrate, dextrin, inositol, amylase, water-soluble polysaccharides, pentaerythritol, dipentaerythritol and polyalcohols. Also disclosed are methods for treating wood by pressure impregnation and wood obtained by said methods.
Patent NZ-623921-A (NZ)
Title: Method of activating cascaded electron tubes
Inventor: BIRNBACH CURTIS A
IPC: H01J35/00
Filed: 2009-11-16
Abstract: Disclosed is a method of activating a plurality of cascaded electron tube stages within a common vacuum enclosure. The method includes interconnecting the plurality of cascaded electron tube stages in series, from a non-final stage to a final stage, in such a manner that in each non-final stage an electrode is connected to an electrode of a subsequent stage by a respective electrical interconnection line. At least one of the respective electrical interconnection lines comprises a linking structure for electrically and mechanically joining an electrode of a previous stage with an electrode of a subsequent stage. The method also includes placing the plurality of cascaded electron tube stages within the vacuum enclosure and exhausting air from the enclosure. The method further includes providing electrical voltage between the cathode and anode of a first serially connected stage so as to supply electrical energy to the first stage. The voltage provides a sufficient amount of energy to the first stage that the first stage is activated and energy propagates to through the other stages to activate them.
Patent NZ-625592-A (NZ)
Title: Compositions and methods for the treatment of hepatic diseases and disorders
Inventor: MCKENNA ELIZABETH
IPC: A61K35/742
Filed: 2013-01-16
Abstract: Discloses is a pharmaceutical composition formulated for sublingual or buccal administration, which comprises: (a) a lysate or cell wall extract from a Gram-positive bacteria, or a pharmaceutically acceptable salt thereof, in an amount ranging from 1 mg/kg to 100 mg/kg; (b) an oral-mucosa-transit promoter to assist in the therapeutic delivery of the said lysate or cell wall extract from a Gram-positive bacteria, or a pharmaceutically acceptable salt thereof, across a subject’s oral mucosa; and (c) an optional carrier, wherein the composition is formulated to completely dissolve in not less than 1 minute after administration. The composition is suitable for the treatment of a hepatic disease or disorder selected from hepatitis A infection, hepatitis B infection, hepatitis C infection, acute hepatitis, chronic hepatitis, or fulminant liver failure.
Patent NZ-626254-A (NZ)
Title: Anchor bolt and annularly grooved expansion sleeve assembly exhibiting high pull-out resistance, particularly under cracked concrete test conditions
Inventor: BROOMFIELD DONALD
IPC: F16B13/06
Filed: 2009-02-05
Abstract: A method of perfoming cracked concrete testing for an anchor exhibiting high pull-out resistance. The anchor comprises an anchor bolt member (112) with an enlarged head portion (128) and an expansion sleeve member (114). A plurality of annular grooves (138) are disposed on a forward portion of the sleeve (114) while the rearward portion is non-grooved and solid. When the anchor bolt (112) is moved through the expansion sleeve (114) the enlarged head will expand the forward portion of the sleeve (114) so that the grooves are forced into engagement with the borehole. Subsequently the enlarged head will expand the rearward portion to achieve a maximum area and volume of interference with the borehole. The expansion sleeve (114) is tapered with a larger rear end to enhance pull-out resistance.
Patent NZ-701956-A (NZ)
Title: Processes to produce certain 2-(pyridine-3-yl)thiazoles
Inventor: DEAMICIS CARL
IPC: C07D417/04
Filed: 2013-05-30
Abstract: The invention disclosed in this document is related to the field of processes to produce certain 2-(pyridine-3-yl)thiazoles as intermediates for the synthesis of pesticidal thiazole amides. Compounds (I) and (II) are cyclized to produce compound (III). This step is conducted in the presence of a base when compound (II) is in the form of a salt. Suitable bases include, but are not limited to, sodium bicarbonate, potassium bicarbonate, sodium carbonate, cesium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, sodium bisulfate, sodium acetate, potassium acetate, ammonium hydroxide, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, triethylamine and pyridine. The reaction can be conducted at ambient temperature and pressure, but higher or lower temperatures and pressures can be used, if desired. The reaction is conducted in a polar protic solvent. Examples of such solvents include, but are not limited to, n-butanol, isopropanol, n-propanol, ethandl, methanol, and water.